Patent ID: 8277835

Claim:
A method of reducing the incidence of upper respiratory tract infection episodes comprising administering to an infant mammal in need thereof a liquid infant formula composition consisting of: (a) 0.5-10 grams transgalactooligosaccharide per 100 grams dry weight of the composition, (b) 0.5-10 grams fructopolysaccharide per 100 grams dry weight of the composition, (c) optionally, indigestible dextrins, xylooligosaccharides, arabinooligosaccharides, glucooligosaccharides, mannooligosaccharides, fucooligosaccharides, fructans, fructooligosaccharide, hydrolysed inulin, inulin or lactose, and (d) optionally, a long chain polyunsaturated fatty acid (LC-PUFA), wherein, as a percentage of the total caloric value of the composition, (i) 35-50% energy is derived from fat; (ii) 7.5-12.5% energy is derived from protein; and 40-55% energy is derived from carbohydrate; and wherein the composition is in the form of a liquid and does not comprise human milk.